Skip to content
StockMarketAgent
Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

ISE/UPR stock hub

ISE/UPR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ISE/UPRis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.1B
Euronext Dublin
Market data

Live price

Current market quote for this ticker.

Current price
ISE/UPR
In the news

Latest news · ISE/UPR

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.5
P25 n/aP50 n/aP75 n/a
Trailing P/E22
P25 n/aP50 n/aP75 n/a
ROE12.7
P25 n/aP50 n/aP75 n/a
ROIC10.1
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ISE/UPR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
235
Groups with data
11
Currency
EUR
Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
Ireland
Country code
IE
Employees
3,500
Employees Change
500%
Employees Change Percent
16.67
Enterprise value
EUR 1.4B
Exchange
Euronext Dublin
Financial currency
EUR
First seen
2026-05-10
Industry
Medical Distribution
Isin
IE00BJ5FQX74
Last refreshed
2026-05-10
Market cap
EUR 1.1B
Price
EUR 4.3
Price currency
EUR
Rev Per Employee
878,486.86x
Sector
Healthcare
Sic
5122
Symbol
ise/UPR
Website
https://www.uniphar.ie

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

15
MetricValue
Earnings Yield
4.58%
EV Earnings
28.27x
EV/EBIT
15.79x
EV/EBITDA
11.7x
EV/FCF
17.01x
EV/Sales
0.47x
FCF yield
7.61%
Forward P/E
16.55x
P/B ratio
2.75x
P/E ratio
22.03x
P/S ratio
0.36x
PE Ratio10 Y
18.29x
PE Ratio3 Y
13.8x
PE Ratio5 Y
14.34x
PEG ratio
1.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

26
MetricValue
EBIT Margin
2.97%
EBITDA Margin
3.49%
FCF margin
2.76%
Gross margin
14.89%
Gross Profit
EUR 457.7M
Gross Profit Growth
3.89%
Gross Profit Growth Q
7.76%
Gross Profit Growth3 Y
3.85%
Gross Profit Growth5 Y
5.6%
Net Income
EUR 51.1M
Net Income Growth
-20.43%
Net Income Growth Q
-31.16%
Net Income Growth Years
0%
Net Income Growth3 Y
4.19%
Net Income Growth5 Y
2.78%
Pretax Margin
2.05%
Profit Margin
1.66%
Profit Per Employee
EUR 14,597
Profitable Years
8
ROA
3.63
Roa5y
3.96
ROCE
10.19
ROE
12.67
Roe5y
16.54
ROIC
10.12
Roic5y
11.63

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

25
MetricValue
Cagr1y
36.28%
Cagr3y
14.07%
Cagr5y
8.07%
Div CAGR3
5.1%
Div CAGR5
5.6%
EPS Growth
-17.02
EPS Growth Q
-27.59
EPS Growth Years
0
EPS Growth3 Y
5.73
EPS Growth5 Y
3.66
FCF Growth
89.85%
FCF Growth Q
2,017.68%
FCF Growth3 Y
-3.74%
FCF Growth5 Y
13.88%
OCF Growth
-12.74%
OCF Growth Q
52.57%
OCF Growth10 Y
5.09%
OCF Growth3 Y
-5.88%
OCF Growth5 Y
12.89%
Revenue Growth
10.98x
Revenue Growth Q
13.28x
Revenue Growth Quarters
7x
Revenue Growth Years
8x
Revenue Growth3 Y
4.67x
Revenue Growth5 Y
5.81x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
EUR 1.95
Assets
EUR 1.7B
Cash
EUR 183.7M
Current Assets
EUR 828.9M
Current Liabilities
EUR 834.9M
Debt
EUR 512.7M
Debt EBITDA
EUR 4.15
Debt Equity
EUR 1.27
Debt FCF
EUR 6.04
Equity
EUR 405.2M
Interest Coverage
4.49
Liabilities
EUR 1.3B
Long Term Assets
EUR 903.3M
Long Term Liabilities
EUR 492.2M
Net Cash
EUR -329M
Net Cash By Market Cap
EUR -29.51
Net Debt EBITDA
EUR 3.06
Net Debt Equity
EUR 0.81
Net Debt FCF
EUR 3.88
Tangible Book Value
EUR -188.1M
Tangible Book Value Per Share
EUR -0.72
WACC
8.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.99
Inventory Turnover
10.53
Net Working Capital
EUR -167.3M
Quick ratio
0.61
Working Capital
EUR -5.9M
Working Capital Turnover
EUR -74.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
4.1%
Dividend Growth
5.21%
Dividend Growth Years
3%
Dividend per share
EUR 0.02
Dividend Years
7
Dividend Yield
0.47%
Ex Div Date
2026-04-23
Last Dividend
EUR 0.01
Payout Frequency
Semi-Annual
Payout Ratio
9.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

37
MetricValue
1Y total return
36.25%
200-day SMA
3.87
3Y total return
48.44%
50-day SMA
4
50-day SMA vs 200-day SMA
50over200
5Y total return
47.4%
All Time High
5.08
All Time High Change
-15.45%
All Time High Date
2022-01-04
All Time Low
0.97
All Time Low Change
345.08%
All Time Low Date
2020-03-19
ATR
0.11
Beta
1.13
Beta1y
0.57
Beta2y
0.79
Ch YTD
22.02
High
4.32
High52
4.35
High52 Date
2026-05-07
High52ch
-1.26%
Low
4.26
Low52
3.17
Low52 Date
2025-05-08
Low52ch
35.7%
Ma50ch
7.27%
Price vs 200-day SMA
10.9%
RSI
65.76
RSI Monthly
65.51
RSI Weekly
63.07
Sharpe ratio
0.86x
Sortino ratio
1.6
Total Return
4.57%
Tr YTD
22.41
Tr1m
10.62%
Tr1w
2.63%
Tr3m
6.92%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
EUR 91.4M
Operating Income Growth
2.11
Operating Income Growth Q
8.8
Operating Income Growth3 Y
5.02
Operating Income Growth5 Y
4.66
Operating margin
2.97

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
233,753,035%
Net Borrowing
90,292,000
Shares Insiders
5.07%
Shares Institutions
54.66%
Shares Out
259,574,298
Shares Qo Q
-1.73%
Shares Yo Y
-4.1%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
EUR 81.1M
Average Volume
446,978.3x
Bv Per Share
1.56
CAPEX
EUR -23.5M
Ch1m
10.27
Ch1w
2.63
Ch1y
35.57
Ch3m
6.58
Ch3y
45.59
Ch5y
43.17
Ch6m
14.38
Change
-0.12%
Change From Open
0.23
Close
4.3
Days Gap
-0.35
Depreciation Amortization
16,018,000
Dollar Volume
1,302,201.1
Earnings Date
2026-06-02
EBIT
EUR 91.4M
EBITDA
EUR 107.4M
EPS
EUR 0.2
F Score
6
FCF
EUR 84.9M
FCF EV Yield
5.88x
FCF Per Share
EUR 0.33
Financing CF
50,168,000
Fiscal Year End
December
Founded
1,967
Goodwill
499,567,000
Graham Number
2.61641
Graham Upside
-39.08
Income Tax
EUR 11.8M
Investing CF
-77,129,000
Is Primary Listing
1
Last Earnings Date
2026-02-24
Last Report Date
2025-12-31
Lynch Fair Value
EUR 0.98
Lynch Upside
-77.3
Ma150
3.85
Ma150ch
11.67%
Ma20
4.1
Ma20ch
4.83%
Net CF
80,705,000
Next Earnings Date
2026-06-02
Open
4.29
P FCF Ratio
13.13
P OCF Ratio
10.28
Payment Date
2026-05-15
Position In Range
61.54
Ppne
301,162,000
Price Date
2026-05-08
Price EBITDA
EUR 10.38
Relative Volume
0.7x
Revenue
3,074,704,000x
SBC By Revenue
0.12x
Share Based Comp
3,766,000
Tax By Revenue
0.38x
Tax Rate
18.77%
Tr6m
14.75%
Volume
303,190
Z Score
2.5
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

ISE/UPR dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+0.5%
$0.02 annual per share
Payout ratio
+9.9%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+5.6%
3 consecutive years of growth
Total shareholder yield
+4.6%
Next ex-dividend date: 2026-04-23
Performance

ISE/UPR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+36.2%
S&P 500 1Y: n/a
3Y total return
+48.4%
S&P 500 3Y: n/a
5Y total return
+47.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns ISE/UPR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+54.7%
Share of float held by funds and institutions
Insider ownership
+5.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
-4.1%
Negative means the company is buying back shares.
Technical

ISE/UPR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
65.8
Neutral momentum band
Price vs 200-day MA
+10.9%
50/200-day relationship not available
Beta (5Y)
1.13
Moves roughly with the market
Sharpe ratio
0.86
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ISE/UPR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ise/UPR stock rating?

ise/UPR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ise/UPR analysis?

The full report lives at /stocks/ise/UPR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ise/UPR?

The latest report frames ise/UPR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ise/UPR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.